Tim-3 was significantly elevated in patients with COVID-19 relative to non-COVID-19 controls who were treated in the ICU setting while MCP-4 levels were not significantly different between the two groups (Figure 1B). This evidence concerns the gene HAVCR2 and COVID-19.